SeaStar Medical is trading at $5.18, up 10.45% in pre-market, amid the availability of new ICD-10-PCS codes for its SCD therapy; available reporting does not establish that the codes caused the rise.
- The codes became available October 1, supporting inpatient billing and reporting for acute kidney injury treatment.
- Shares closed up 25.07% on October 2, amid substantial recent volatility.